Sell signal, week 2
Beam Therapeutics drops 8.8% as the sell signal climbs to 3rd place
Sell signal, week 2
Our view last week
Beam Therapeutics stock drops 15.8% in a week ruled by sellers: the rebound attempt collapsed against an extreme wave of selling in the final session, with the stock already deep in a distribution phase. The weekly technical analysis marks it out: a fresh sell signal, ranking second among the 140 US stocks on our sell list. Volatility stays very high: opening a position now, per our model, is high-risk.
This week's summary
Beam Therapeutics stock drops another 8.8% in a week ruled by sellers: buyers nearly vanished and the stock stays deep in a distribution phase. This is the confirmation week for the sell signal, closing lower — our model calls for holding the position unchanged. The sell signal climbs to third among the 141 US stocks on our sell list in this week's technical analysis, with volatility staying very high: opening a position now is high-risk.
Sell signal in observation
·2nd week from start
·US stocks
·T2
·📅 Earnings · Aug 11
★ See Gold version →
IQS Phase
87
in tension / maturity
Signal Strength
100
downtrend making lower lows, pace holding
Sizing
STANDARD
Ranking
#3 / 141
US stocks sell signals
Trade P&L %
+8.83%
from signal to today
Rank position
ranks 3rd among the 141 sell signals for US stocks in our ranking, with a signal strength of 100 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly +0.92% · monthly +6.01%
BEAM belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content